Summit Partners-backed Dreampath Diagnostics Acquired by Halma plc

STRASBOURG, FRANCE; BOSTON; AND LONDON – Global growth equity investor Summit Partners today announced that Dreampath Diagnostics, a leading provider of automated workflow solutions for anatomical pathology laboratories, has been acquired by Halma plc (LON: HLMA). Summit Partners announced a growth investment in Dreampath in July 2025.

Founded in 2012 and headquartered in Strasbourg, France, Dreampath designs automated workflow systems that help anatomical pathology laboratories track, store and retrieve patient tissue samples accurately and efficiently throughout the diagnostic process. Since Summit's investment, Dreampath has expanded its product and service offerings, working to broaden its platform to better serve the evolving needs of pathology labs worldwide. Today, the company manages more than 300 million samples across over 500 labs in 50 countries.

“We’re grateful to Summit Partners for their partnership and support during such an important period in Dreampath’s journey. Their confidence as our first institutional investor helped us accelerate our growth, strengthen our platform, and reach more labs and patients around the world,” said Pablo Jordan, CEO of Dreampath Diagnostics. “We’re excited to build on that momentum in our next chapter.”

“Dreampath has built a category-leading platform that we believe addresses a critical bottleneck in the pathology workflow, replacing manual, error-prone processes that can have real consequences for patient safety,” said Thomas Tarnowski, Managing Director at Summit Partners. “It has been a privilege to partner with Pablo and the team and we’re proud of their impact across the customers and patients they serve.”

“From our first conversations, Dreampath stood out to us for its leadership, quality focus and strong customer adoption,” added Jono Pagden, Partner at Summit Partners. “Over the course of our partnership, the team expanded their platform and reach while staying true to their core mission of helping labs protect patients, sample by sample. We’re proud to have supported their growth.”

‍

About Dreampath Diagnostics
Dreampath Diagnostics is a France-based specialist in automated workflow solutions for anatomical pathology laboratories. Founded in 2012 and headquartered in Strasbourg, the company designs and supplies systems that help laboratories track, store and retrieve patient tissue samples accurately and efficiently throughout the diagnostic process. Dreampath’s solutions improve sample traceability, reduce manual handling and support reliable diagnosis in a highly regulated part of healthcare. www.dreampathdx.net.

About Summit Partners
Summit Partners is a global growth equity firm that invests across growth sectors of the economy and, since the firm’s founding in 1984, has invested in more than 550 companies in technology, healthcare, and other growth industries. Summit maintains offices in North America and Europe and seeks to invest in category-leading, profitable growth companies worldwide. For more information, please visit www.summitpartners.com or follow Summit Partners on LinkedIn.